Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
2
×
detroit blog main
detroit top stories
life sciences
medical devices
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
2
×
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
synlogic
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accelerator
accent therapeutics
achilles therapeutics
airbnb
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amazon web services (aws)
amgen
aridis pharmaceuticals
aristea therapeutics
What
admits
advantages
ago
bar
big
bio
biotechs
brings
classes
combinator
companies
drug
dug
expect
gamble
incubator
life
market
medco’s
mover
new
patients
payers
physicians
plan
previously
pricing
roundup
sciences
sets
sizable
started
startup
tech
they’re
type
ubiome
undone
vertex’s
welcome
Language
unset
Current search:
synlogic
×
cancer
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone